ECS Historical Cash Flow

ECS Stock

0.02 0 6.25%

Analysis of ECS Botanics cash flow over time is an excellent tool to project ECS Botanics Holdings future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Income of 2 M or End Period Cash Flow of 2.2 M as it is a great indicator of ECS Botanics ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining ECS Botanics Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ECS Botanics Holdings is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ECS Botanics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About ECS Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in ECS balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which ECS's non-liquid assets can be easily converted into cash.

ECS Botanics Cash Flow Chart

At this time, ECS Botanics' Change To Operating Activities is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 5.1 M in 2024, despite the fact that Free Cash Flow is likely to grow to (3.7 M).

Capital Expenditures Net Income End Period Cash Flow Change In Cash Free Cash Flow Investments

Capital Expenditures

Capital Expenditures are funds used by ECS Botanics Holdings to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of ECS Botanics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in ECS Botanics Holdings financial statement analysis. It represents the amount of money remaining after all of ECS Botanics Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Most accounts from ECS Botanics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into ECS Botanics Holdings current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ECS Botanics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2023	2024 (projected)
Depreciation	1.3M	1.4M
Dividends Paid	2.6M	2.7M

Depreciation Dividends Paid

ECS Botanics cash flow statement Correlations

	Other Non Cash Items	Capital Expenditures	Net Income	End Period Cash Flow	Change In Cash	Free Cash Flow	Begin Period Cash Flow	Sale Purchase Of Stock	Dividends Paid	Depreciation	Investments	Change In Working Capital	Change To Account Receivables	Change To Inventory	Net Borrowings	Change To Operating Activities	Issuance Of Capital Stock	Change To Netincome	Change To Liabilities	Stock Based Compensation
Other Non Cash Items		-0.02	-0.94	0.28	0.52	0.03	-0.49	0.04	0.05	0.22	0.11	0.05	0.1	0.0	-0.1	-0.12	0.09	0.26	0.08	0.03
Capital Expenditures	-0.02		-0.05	0.05	-0.01	-0.87	0.07	0.57	0.33	0.3	-0.71	-0.31	-0.45	-0.31	0.57	0.61	-0.26	-0.39	0.14	0.4
Net Income	-0.94	-0.05		-0.33	-0.49	0.06	0.4	-0.26	-0.02	-0.1	-0.03	-0.26	0.04	-0.27	0.31	0.32	-0.32	-0.41	0.06	-0.24
End Period Cash Flow	0.28	0.05	-0.33		0.76	0.02	-0.1	0.03	-0.1	0.34	-0.03	0.09	0.13	0.02	-0.03	-0.03	0.12	0.02	0.1	0.2
Change In Cash	0.52	-0.01	-0.49	0.76		0.03	-0.72	0.05	0.07	-0.03	-0.05	0.1	0.08	-0.02	0.03	0.02	0.07	0.12	0.24	0.18
Free Cash Flow	0.03	-0.87	0.06	0.02	0.03		-0.03	-0.79	-0.3	-0.05	0.85	0.47	0.53	0.27	-0.29	-0.35	0.09	0.12	0.25	-0.35
Begin Period Cash Flow	-0.49	0.07	0.4	-0.1	-0.72	-0.03		-0.04	-0.18	0.41	0.05	-0.06	0.01	0.06	-0.08	-0.06	0.02	-0.16	-0.26	-0.06
Sale Purchase Of Stock	0.04	0.57	-0.26	0.03	0.05	-0.79	-0.04		0.09	-0.34	-0.73	-0.02	-0.43	0.16	-0.24	-0.19	0.46	0.44	-0.33	0.68
Dividends Paid	0.05	0.33	-0.02	-0.1	0.07	-0.3	-0.18	0.09		0.01	-0.29	-0.3	-0.02	-0.34	0.33	0.34	-0.21	-0.2	0.15	0.03
Depreciation	0.22	0.3	-0.1	0.34	-0.03	-0.05	0.41	-0.34	0.01		0.09	-0.35	0.17	-0.43	0.51	0.51	-0.46	-0.56	0.23	-0.24
Investments	0.11	-0.71	-0.03	-0.03	-0.05	0.85	0.05	-0.73	-0.29	0.09		0.48	0.16	0.36	-0.23	-0.28	-0.15	0.14	0.16	-0.59
Change In Working Capital	0.05	-0.31	-0.26	0.09	0.1	0.47	-0.06	-0.02	-0.3	-0.35	0.48		-0.15	0.87	-0.54	-0.57	0.48	0.42	0.08	0.25
Change To Account Receivables	0.1	-0.45	0.04	0.13	0.08	0.53	0.01	-0.43	-0.02	0.17	0.16	-0.15		-0.42	0.02	-0.01	0.2	0.02	0.44	0.15
Change To Inventory	0.0	-0.31	-0.27	0.02	-0.02	0.27	0.06	0.16	-0.34	-0.43	0.36	0.87	-0.42		-0.77	-0.77	0.55	0.5	-0.42	0.11
Net Borrowings	-0.1	0.57	0.31	-0.03	0.03	-0.29	-0.08	-0.24	0.33	0.51	-0.23	-0.54	0.02	-0.77		1.0	-0.8	-0.79	0.62	-0.16
Change To Operating Activities	-0.12	0.61	0.32	-0.03	0.02	-0.35	-0.06	-0.19	0.34	0.51	-0.28	-0.57	-0.01	-0.77	1.0		-0.79	-0.8	0.57	-0.14
Issuance Of Capital Stock	0.09	-0.26	-0.32	0.12	0.07	0.09	0.02	0.46	-0.21	-0.46	-0.15	0.48	0.2	0.55	-0.8	-0.79		0.7	-0.32	0.64
Change To Netincome	0.26	-0.39	-0.41	0.02	0.12	0.12	-0.16	0.44	-0.2	-0.56	0.14	0.42	0.02	0.5	-0.79	-0.8	0.7		-0.27	0.3
Change To Liabilities	0.08	0.14	0.06	0.1	0.24	0.25	-0.26	-0.33	0.15	0.23	0.16	0.08	0.44	-0.42	0.62	0.57	-0.32	-0.27		0.19
Stock Based Compensation	0.03	0.4	-0.24	0.2	0.18	-0.35	-0.06	0.68	0.03	-0.24	-0.59	0.25	0.15	0.11	-0.16	-0.14	0.64	0.3	0.19

Click cells to compare fundamentals

ECS Botanics Account Relationship Matchups

ECS Botanics cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Non Cash Items	3.8M	437.4K	(2.1M)	(1.5M)	20.7K	19.7K
Capital Expenditures	1.5M	3.4M	2.9M	3.3M	2.4M	2.5M
Net Income	(4.6M)	(4.3M)	166.2K	491.4K	1.9M	2.0M
End Period Cash Flow	1.9M	4.2M	1.9M	2.5M	3.2M	2.2M
Change In Cash	1.7M	2.3M	(2.4M)	676.1K	615.2K	646.0K
Free Cash Flow	(4.4M)	(5.7M)	(7.6M)	(2.9M)	(3.9M)	(3.7M)
Begin Period Cash Flow	203.0K	1.9M	4.2M	1.9M	2.5M	1.4M
Other Cashflows From Financing Activities	6.1M	(3.2K)	(6.0K)	(44.3K)	(165.7K)	(157.4K)
Total Cash From Financing Activities	6.1M	9.2M	6.2M	310.8K	4.5M	3.3M
Depreciation	22.4K	187.9K	662.4K	1.0M	1.3M	1.4M
Total Cashflows From Investing Activities	(2.2M)	(4.6M)	(3.9M)	(37.4K)	(33.6K)	(35.3K)
Total Cash From Operating Activities	(2.9M)	(2.3M)	(4.7M)	402.7K	(1.5M)	(1.6M)
Other Cashflows From Investing Activities	(750K)	(200K)	(936K)	3.1M	3.5M	3.7M
Change In Working Capital	(987.7K)	1.0M	(3.4M)	1.8M	(5.0M)	(4.7M)
Change To Account Receivables	(766.4K)	44.0K	(1.3M)	(1.3M)	398.1K	418.0K
Change To Inventory	(474.6K)	104.8K	(28.9K)	648.0K	(5.1M)	(4.9M)
Issuance Of Capital Stock	6.1M	9.2M	6.2M	3.8M	3.4M	5.1M
Change To Netincome	2.6M	875.6K	(948.2K)	(2.4M)	(2.1M)	(2.0M)
Change To Liabilities	118.4K	665.1K	(2.3M)	1.2M	1.1M	1.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for ECS Stock Analysis

When running ECS Botanics' price analysis, check to measure ECS Botanics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECS Botanics is operating at the current time. Most of ECS Botanics' value examination focuses on studying past and present price action to predict the probability of ECS Botanics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ECS Botanics' price. Additionally, you may evaluate how the addition of ECS Botanics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC